The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Data Availability
All data are included in the manuscript
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (422)
- Allergy and Immunology (746)
- Anesthesia (217)
- Cardiovascular Medicine (3215)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13229)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5051)
- Geriatric Medicine (469)
- Health Economics (772)
- Health Informatics (3174)
- Health Policy (1126)
- Hematology (421)
- HIV/AIDS (998)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4794)
- Nursing (253)
- Nutrition (712)
- Oncology (2470)
- Ophthalmology (699)
- Orthopedics (278)
- Otolaryngology (336)
- Pain Medicine (319)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1274)
- Primary Care Research (548)
- Public and Global Health (7356)
- Radiology and Imaging (1666)
- Respiratory Medicine (965)
- Rheumatology (472)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (228)
- Urology (199)